BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TherapeuticsMD, Inc. (Nasdaq
globenewswire.com
news
2022-05-31 00:00:00

BALA CYNWYD, Pa., May 31, 2022 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. TherapeuticsMD, Inc. (Nasdaq - TXMD) Under the terms of the agreement, TherapeuticsMD will be acquired by an affiliate of EW Healthcare Partners. EW Healthcare Partners will commence a tender offer to acquire all outstanding shares of TXMD common stock for $10.
